Potential role of mesenchymal stromal cells in pancreatic islet transplantation (Q38071770)

28 August 2017

1 reference

title

Potential role of mesenchymal stromal cells in pancreatic islet transplantation (English)

1 reference

28 August 2017

4

Dixon Kaufman

1 reference

28 August 2017

Peiman Hematti

1

1 reference

PubMed ID

23290684

28 August 2017

Jaehyup Kim

series ordinal

2

1 reference

PubMed ID

23290684

28 August 2017

Andrew P Stein

series ordinal

3

1 reference

28 August 2017

3 January 2013

1 reference

28 August 2017

Transplantation Reviews

1 reference

28 August 2017

27

1 reference

28 August 2017

1

1 reference

28 August 2017

21-29

1 reference

Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation

28 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

The pathogenesis of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Insulin therapy versus cell-based therapy for type 1 diabetes mellitus: what lies ahead?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

7 January 2021

Pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Advances in pancreatic islet transplantation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Transplantation of isolated pancreatic islets into the portal vein of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Five-year follow-up after clinical islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

International trial of the Edmonton protocol for islet transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Pancreatic islet cell transplantation: update and new developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Islet transplantation: lessons learned since the Edmonton breakthrough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Islet transplantation in type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Islet transplantation a decade later and strategies for filling a half-full glass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Current advances and travails in islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Counterpoint: clinical islet transplantation: not ready for prime time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Pancreatic islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Role of mesenchymal stromal cells in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Hemopoietic stromal microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Cardiomyocytes can be generated from marrow stromal cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Adult bone marrow stromal cells differentiate into neural cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Marrow stromal cells as stem cells for nonhematopoietic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Expansion of mesenchymal stem cells from human pancreatic ductal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells reside within the connective tissues of many organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Recent advances into the understanding of mesenchymal stem cell trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells as trophic mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Why are MSCs therapeutic? New data: new insight.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Immune plasticity of bone marrow-derived mesenchymal stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Multipotent mesenchymal stromal cells and immune tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Immunomodulatory properties of mesenchymal stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human mesenchymal stem cells modulate B-cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells in hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Concise review: hitting the right spot with mesenchymal stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Cell therapy approaches for lung diseases: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Autologous mesenchymal stem cell transplantation in stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Wound therapy by marrow mesenchymal cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells protect islets from hypoxia/reoxygenation-induced injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Bone marrow-derived mesenchymal stromal cells support rat pancreatic islet survival and insulin secretory function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Mesenchymal stem cells derived from human exocrine pancreas express transcription factors implicated in beta-cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Isolated human islets contain a distinct population of mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Stromal cell associated haemopoiesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2012.11.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRRE.2012.11.003

1 reference

28 August 2017

1 reference

PubMed ID

23290684